We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The federal government is looking for a partner to collaborate on developing a new treatment for anxiety and depression based on a chemical by-product produced when the body breaks down the drug ketamine. Read More
Boehringer Ingelheim posted positive trial results for another Humira biosimilar, just a month after the FDA approved Amgen’s version, Amjevita. Read More
A year after the first approval of a treatment for female sexual desire disorders, the FDA has released draft guidance for drugmakers looking to develop the next female Viagra. Read More